nitroblue tetrazolium has been researched along with Cardiac Diseases in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Berthod, F; Dittmar, A; Dureau, G; Ferrera, R; Guidollet, J; Larese, A; Rodriguez, C | 1 |
| Acosta, D; Chacon, E | 1 |
2 other study(ies) available for nitroblue tetrazolium and Cardiac Diseases
| Article | Year |
|---|---|
Quantitative reduction of MTT by hearts biopsies in vitro is an index of viability.
Topics: Adenine Nucleotides; Animals; Biopsy; Cell Survival; Female; Heart Diseases; Ischemia; Male; Myocardium; NADH Tetrazolium Reductase; Nitroblue Tetrazolium; Oxidation-Reduction; Oxygen Consumption; Swine; Time Factors | 1993 |
Mitochondrial regulation of superoxide by Ca2+: an alternate mechanism for the cardiotoxicity of doxorubicin.
Topics: Animals; Biological Transport; Calcium; Cell Survival; Cells, Cultured; Doxorubicin; Fluoresceins; Free Radicals; Heart Diseases; L-Lactate Dehydrogenase; Membrane Potentials; Mitochondria, Heart; Nitroblue Tetrazolium; Rats; Rats, Inbred Strains; Ruthenium Red; Superoxides | 1991 |